ID Name Structure References (top 5) Molecular Target(s)
1ID:8093
ALPHA-TOCOPHEROL E

Freqency:
in 2 ingredients:

  • 14
  • 612
  • in 36 recipes:

  • 4
  • 6
  • 8
  • 43
  • 98
  • 114
  • 138
  • 145
  • 150
  • 152
  • 154
  • 165
  • 166
  • 196
  • 206
  • 208
  • 210
  • 212
  • 219
  • 226
  • 228
  • 231
  • 274
  • 289
  • 320
  • 364
  • 378
  • 415
  • 428
  • 434
  • 445
  • 464
  • 465
  • 519
  • 521
  • 527

  • Properties
    C29H50O2    430.71





    1:  Graat JM, Schouten EG, Kok FJ.
    Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial.
    JAMA.    impact factor:   15.402
    2002;  288(6): 715-21

    2:  Gysin R, Azzi A, Visarius T.
    Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins.
    FASEB J.    impact factor:   11.88
    2002;  16(14): 1952-4

    3:  [No authors listed]
    MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.
    Lancet.    impact factor:   10.197
    2002;  360(9326): 23-33

    4:  Hodis HN, Mack WJ, LaBree L, Mahrer PR, Sevanian A, Liu CR, Liu CH, Hwang J, Selzer RH, Azen SP.
    Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS).
    Circulation.    impact factor:   9.903
    2002;  106(12): 1453-9

    5:  Kajikawa M, Fujimoto S, Tsuura Y, Mukai E, Takeda T, Hamamoto Y, Takehiro M, Fujita J, Yamada Y, Seino Y.
    Ouabain suppresses glucose-induced mitochondrial ATP production and insulin release by generating reactive oxygen species in pancreatic islets.
    Diabetes.    impact factor:   9.019
    2002;  51(8): 2522-9

     
    Time used: 110 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005